Discontinuation report OPTIMARK
Report ID | 8842 |
Drug Identification Number | 02242986 |
Brand name | OPTIMARK |
Common or Proper name | GADOVERSETAMIDE INJECTION |
Company Name | LIEBEL-FLARSHEIM CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GADOVERSETAMIDE |
Strength(s) | 330.9MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5, 10, 15, 20mL vials |
ATC code | V08CA |
ATC description | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-12-31 |
Actual discontinuation date | 2018-03-23 |
Remaining supply date | 2018-03-23 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7500 TRANSCANADA HIGHWAY POINTE-CLAIRE, QUEBEC CANADA H9R 5H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2018-03-28 | French | Compare |
v8 | 2018-03-28 | English | Compare |
v7 | 2018-03-28 | French | Compare |
v6 | 2018-03-28 | English | Compare |
v5 | 2018-03-28 | English | Compare |
v4 | 2018-01-22 | French | Compare |
v3 | 2018-01-22 | English | Compare |
v2 | 2017-05-03 | French | Compare |
v1 | 2017-05-03 | English | Compare |
Showing 1 to 9 of 9